Stock listing

Stockholm:IMMNOV Immunovia AB Aktie

Home listing (Stockholm) of Immunovia AB

Follow Immunovia AB into a list and get an email when it puts out news.

Share price · OMXSTO:IMMNOV

0.052 SEK +0.001 (+2.8%)

Close on Nov 2, 2026

Past year -83.9% · daily closes, Nov 3, 2025 – Nov 2, 2026, adjusted for splits
Day range
0.051 – 0.061 SEKNov 2, 2026
Volume
9.91M sharesNov 2, 2026
Market cap
34.64M SEKAt the close on Nov 2, 2026 · price × 672.7M shares outstanding
52-week range
0.040 – 0.360 SEKLowest and highest trades, Nov 3, 2025 – Nov 2, 2026
Traded on an average day
562,049 SEKMedian day 3.03M shares · last 3 months, Aug 3, 2026 – Nov 2, 2026
Immunovia AB logo

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
Stockholm:IMMNOV · Home0.052 SEK+0.001 (+2.8%)9,905,9750.0550.0610.0510.050Close on Nov 2, 2026
LSE:0G8X0.071 SEK-0.016 (-18.4%)500,0000.0710.0710.0710.087Close on Oct 27, 2026
Frankfurt:1YR€0.0001 EUR-0.0013 (-92.9%)—€0.0001€0.0001€0.0001€0.0014Close on Oct 30, 2026

Daily closes

Last 3 months, Aug 3, 2026 – Nov 2, 2026 · OMXSTO:IMMNOV · SEK, adjusted for splits

DayCloseChange%OpenHighLowVolume
0.052+0.001+2.8%0.0550.0610.0519,905,975
0.050+0.006+13.9%0.0480.0600.04616,206,352
0.044-0.026-36.8%0.0530.0580.04030,299,179
0.070+0.000+0.4%0.0690.0710.0671,803,531
0.069-0.003-3.5%0.0730.0730.0674,671,212
0.0720.000-0.3%0.0720.0750.0702,436,243
0.072-0.001-1.4%0.0730.0750.0712,473,256
0.073-0.004-5.2%0.0770.0780.0711,245,333
0.077-0.007-7.9%0.0830.0840.0709,843,855
0.084+0.003+4.4%0.0800.0860.080621,806
0.080-0.008-9.6%0.0820.0880.0802,308,072
0.089-0.003-3.6%0.0920.0920.0805,169,914
0.092+0.018+25.0%0.0740.1100.07417,954,903
0.074-0.007-8.1%0.0800.0800.0722,536,757
0.080+0.004+5.7%0.0810.0820.0753,568,637
0.076-0.003-4.2%0.0850.0850.0753,871,036
0.079+0.009+12.1%0.0730.0790.06620,497,114
0.071+0.009+14.8%0.0620.0740.06113,834,681
0.061-0.003-4.8%0.0640.0700.0606,466,970
0.065-0.007-9.3%0.0690.0730.0606,205,053
0.071-0.005-6.4%0.0750.0750.0667,513,861
0.076-0.009-10.6%0.0860.0880.0728,903,836
0.085-0.008-8.6%0.0940.0950.0838,240,299
0.093-0.004-4.0%0.0970.1000.0926,177,747
0.097-0.043-30.8%0.1030.1070.09124,415,043
0.140+0.000+0.1%0.1390.1500.1006,928,343
0.140+0.002+1.5%0.1380.1420.1351,487,514
0.138+0.004+3.1%0.1350.1430.1341,917,609
0.134-0.003-2.2%0.1300.1390.1294,409,126
0.137-0.006-4.2%0.1420.1430.1361,741,874
0.143-0.006-3.9%0.1480.1500.1362,526,901
0.148-0.003-1.7%0.1470.1500.145901,717
0.151-0.001-0.7%0.1490.1540.1473,046,064
0.152-0.007-4.5%0.1510.1550.1461,849,969
0.159+0.002+1.4%0.1580.1590.1501,672,070
0.157+0.014+9.9%0.1450.1620.1455,778,235
0.143+0.001+0.6%0.1420.1470.1392,202,786
0.142-0.006-4.2%0.1490.1500.1421,955,787
0.148-0.002-1.2%0.1550.1610.1393,009,698
0.150-0.018-10.5%0.1620.1670.1467,740,306
0.168+0.038+29.3%0.1300.1800.12514,614,449
0.130-0.002-1.7%0.1300.1310.1254,585,104
0.132-0.001-0.8%0.1330.1330.1271,190,549
0.133+0.001+0.6%0.1320.1330.1281,618,822
0.132-0.009-6.3%0.1410.1410.1276,401,112
0.141-0.002-1.3%0.1440.1440.1381,838,702
0.1430.0000.0%0.1410.1450.1393,360,820
0.1430.0000.0%0.1430.1440.1392,237,596
0.143-0.008-5.3%0.1510.1550.1427,229,753
0.151-0.002-1.4%0.1510.1550.1473,728,896
0.153+0.001+0.4%0.1520.1590.1444,958,717
0.152-0.006-3.7%0.1560.1580.1512,623,989
0.158+0.001+0.4%0.1540.1600.1521,687,733
0.157+0.003+2.2%0.1540.1580.1521,347,285
0.154-0.004-2.3%0.1560.1580.1501,844,128
0.158-0.004-2.2%0.1610.1610.1553,707,143
0.161-0.003-1.7%0.1640.1660.1582,354,934
0.164+0.002+1.1%0.1620.1650.1601,819,442
0.162+0.001+0.4%0.1620.1680.1582,644,743
0.1620.000-0.2%0.1650.1690.1592,894,590
0.162-0.004-2.3%0.1650.1660.1602,523,622
0.166-0.010-5.6%0.1760.1760.1636,020,960
0.176-0.006-3.5%0.1900.1940.1735,403,135
0.182+0.002+1.3%0.1780.1900.1782,663,894
0.180-0.005-2.9%0.1850.1880.1782,704,614
0.185+0.005+3.0%0.1800.1880.1771,311,423
Ticker
Stockholm:IMMNOV
Asset type
Stock
Sector
Health care
Industry
Diagnostics & research services
Exchange
Stockholm
Currency
SEK

What changed lately

Calls

Replays

  • Immunovia (Stockholm:IMMNOV) Q2 2026 Earnings Call

    Thu, Aug 06, 2026 · 9:00 AM ET

    Watch Transcript

  • Immunovia (Stockholm:IMMNOV) Q1 2026 Earnings Call

    Thu, May 07, 2026 · 9:00 AM ET

    Watch Transcript

  • Immunovia (Stockholm:IMMNOV) Q4 2025 Earnings Call

    Tue, Feb 24, 2026 · 9:00 AM ET

    Watch Transcript

Latest news

Immunovia announces final terms of rights issue

Oct 28, 2026

Closed 0.044 (-36.8%) on Oct 29, 2026

Immunovia Publishes Interim Report for April-June 2026

Aug 6, 2026

Closed 0.176 (-3.5%) on Aug 6, 2026

Immunovia announces new performance data for PancreaSure ahead of upcoming application for Medicare coverage

Jun 15, 2026

Closed 0.206 (+14.7%) on Jun 15, 2026

Immunovia publishes final AFFIRM study results in Journal of Clinical Oncology confirming strong diagnostic performance of PancreaSure

Jun 10, 2026

Closed 0.183 (+1.2%) on Jun 10, 2026

Immunovia Publishes Interim Report for January-March 2026

May 7, 2026

Closed 0.205 (+17.0%) on May 7, 2026

Immunovia launches ASSURE registry to evaluate real-world clinical impact of PancreaSure in high-risk pancreatic cancer surveillance

May 5, 2026

Closed 0.184 (-10.7%) on May 5, 2026

Proposal for resolution on (A) option program for board members; and (B) directed issue of warrants and approval of transfer of warrants (Proposal for resolution on A option program for board members and B directed issue of warrants and approval of transfer of warrants 45758458 v6)

May 4, 2026

Closed 0.184 (-10.7%) on May 5, 2026

Proposal for resolution on (A) option program for management and key persons; and (B) directed issue of warrants and approval of transfer of warrants (Proposal for resolution on A option program for management and key persons and B directed issue of warrants and approval of transfer of warrants)

Apr 14, 2026

Closed 0.22 (+1.9%) on Apr 15, 2026

Proposal for resolution on authorization of the board to resolve on new issue of shares (Proposal for resolution on authorization regarding issues)

Apr 14, 2026

Closed 0.22 (+1.9%) on Apr 15, 2026

Annual Report (Immunovia AB publ Annual Report 2025)

Apr 14, 2026

Closed 0.22 (+1.9%) on Apr 15, 2026

All Immunovia AB news

Financings

  • Rights offering of units consisting of shares and warrants of series TO 4

    Oct 28, 2026 · US$6.38M

    Update: about SEK 63.4M · SEK 0.06 a unit · 1 warrant at SEK 0.03 · APREA Partners AB +2

    Dealers: APREA Partners AB (co-lead), Carlsquare AB (co-lead), Vator

    Buyers: Jeff Borcherding (committed to subscribe for at least his pro rata share)

    Insiders: Several board members and management, including CEO Jeff Borcherding, gave subscription undertakings totalling approximately SEK 1 million

    Use of proceeds: US commercialization of PancreaSure incl. sales and marketing, clinical studies to support reimbursement, and working capital

    Update Oct 28, 2026

Read by 6ix AI from the company's releases

Decks

Immunovia AB on 6ix

Sector
Health care
Industry
Diagnostics & research services
News releases
18 in the last 12 months · 18 in all · newest Oct 28, 2026 · oldest 2026
Calls
9 calls with a replay · 9 with a transcript · latest Aug 6, 2026
Decks
13 decks · latest May 7, 2026

Where Immunovia AB is listed

ListingExchangeCountryCurrency
Stockholm:IMMNOV · Home listing · This pageStockholmSwedenSEK
gettex:1YRgettexGermanyEUR
LSE:0G8XLSEUnited KingdomSEK
Aquis:IMMNOSAquisUnited KingdomSEK
Aquis:IMMNOSAquisUnited KingdomSEK
Frankfurt:1YRFrankfurtGermanyEUR
Munich:1YRMunichGermanyEUR
OTC:IMMVFOTCUnited StatesUSD

Log in to ask 6ix AI your own questions about Immunovia AB.